✦ LIBER ✦

An open-label, uncontrolled, 8-week clinical trial of barnidipine hydrochloride, a once-daily calcium channel blocker, in Korean patients with essential hypertension

✍ Scribed by Jong-Hoa Bae; Jyo Jung Lee; Sun Hee Kwon; Heung Sun Kang; Chung Whee Choue; Kwon San Kim; Myung Shick Kim; Jung Sang Song; Minoru Yamamoto

Book ID: 117091116
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 361 KB
Volume: 58
Category: Article
ISSN: 0011-393X
DOI: 10.1016/s0011-393x(97)80098-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Open-label, uncontrolled, clinical trial

Open-label, uncontrolled, clinical trial of barnidipine hydrochloride in Korean patients with renal parenchymal hypertension

✍ Hyeong Cheon Park; Kun Ho Kwon; Hyun Jin Noh; In Hee Lee; Shin Wook Kang; Kyu Hu 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 564 KB

Antihypertensive effect of barnidipine 1

Antihypertensive effect of barnidipine 10 mg or amlodipine 5 to 10 mg once daily in treatment-naive patients with essential hypertension: A 24-week, randomized, open-label, pilot study

✍ Giuseppe Rossetti; Samuele Pizzocri; Francesco Brasca; Marta Pozzi; Laura M. Bel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 762 KB

Efficacy and tolerability of two formula

Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: An 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial

✍ Sang-Hyun Kim; Woo-Young Chung; Joo-Hee Zo; Myung-A Kim; Hyuk-Jae Chang; Young-S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 146 KB